Updated study on risk of cholestatic liver disease and flucloxacillin: Letter to the Editors

British Journal of Clinical Pharmacology

Volumn 68, Issue 2, 2009, Pages 269-270

  Li, Lin ^a   Jick, Hershel ^a   Jick, Susan S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; FLUCLOXACILLIN; PENICILLIN V;

ALCOHOL ABUSE; CHOLESTATIC HEPATITIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DRUG USE; ELECTRONIC MEDICAL RECORD; GALLSTONE; HUMAN; INCIDENCE; INTRAHEPATIC CHOLESTASIS; LETTER; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NEOPLASM; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS HEPATITIS;

CHOLESTASIS; FLOXACILLIN; GREAT BRITAIN; HUMANS; RISK FACTORS;

EID: 68449088887     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03454.x     Document Type: Letter

References (10)

1. Tauris P, Jørgensen NF, Petersen CM, Albertsen K. Prolonged severe cholestasis induced by oxacillin derivatives. A report on two cases. Acta Med Scand 1985 217 : 567 9.
2. Bengtsson F, Floren CH, Hagerstrand I, Soderstrom C, Aberg T. Flucloxacillin-induced cholestatic liver damage. Scand J Infect Dis 1985 17 : 125 8.
3. Turner IB, Eckstein RP, Riley JW, Lunzer MR. Prolonged hepatic cholestasis after flucloxacillin therapy. Med J Aust 1989 151 : 701 5.
4. Derby LE, Jick H, Henry DA, Dean AD. Cholestatic hepatitis associated with flucloxacillin. Med J Aust 1993 158 : 596 600.
5. Jick H, Derby LE, Dean AD, Henry DA. Flucloxacillin and cholestatic hepatitis. Med J Aust 1994 160 : 525.
6. Levy C, Lindor KD. Drug-induced-cholestasis. Clin Liver Dis 2003 7 : 311 30.
7. Russmann S, Kaye JA, Jick SS, Jick H. Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database. Br J Clin Pharmacol 2005 60 : 76 82.
8. Roughead EE, Gilbert AL, Primrose JG. Improving drug use: a case study of events which led to changes in use of flucloxacillin in Australia. Soc Sci Med 1999 48 : 845 53.
9. UK Medicines Control Agency (MCA). Flucloxacillin-induced cholestatic jaundice. Current Problems in Pharmacovigilance 1992 35 : 2.
10. Hayward A, Knott F, Petersen I, Livermore DM, Duckworth G, Islam A, Johnson AM. Increasing hospitalizations and general practice prescriptions for community-onset staphylococcal disease, England. Emerg Infect Dis 2008 14 : 720 6.